LETROZOLE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51991-759 -
Package NDC
51991-759-10 -
Package NDC
51991-759-33 -
Package NDC
51991-759-90 -
Application number
ANDA200161 -
SPL ID
1bd709a7-993a-4e55-9bb5-d5f42678e7b9 -
SPL set ID
63e54b62-a30d-4a56-9215-75e7a0b0bf02 -
UNII
7LKK855W8I -
RxCUI
200064
What the source publishes
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Active ingredients
- LETROZOLE
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LETROZOLE",
"splId": "1bd709a7-993a-4e55-9bb5-d5f42678e7b9",
"labels": [
{
"setId": "63e54b62-a30d-4a56-9215-75e7a0b0bf02",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63e54b62-a30d-4a56-9215-75e7a0b0bf02",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63e54b62-a30d-4a56-9215-75e7a0b0bf02"
}
],
"routes": [
"ORAL"
],
"labeler": "Breckenridge Pharmaceutical, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (51991-759-10)",
"package_ndc": "51991-759-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20110604"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (51991-759-33)",
"package_ndc": "51991-759-33",
"identifierStatus": "well-formed",
"marketing_start_date": "20110604"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (51991-759-90)",
"package_ndc": "51991-759-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20221001"
}
],
"productId": "51991-759_1bd709a7-993a-4e55-9bb5-d5f42678e7b9",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "51991-759",
"deaSchedule": null,
"genericName": "LETROZOLE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LETROZOLE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA200161",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20110604",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175563",
"N0000175080"
],
"upc": [
"0351991759904"
],
"unii": [
"7LKK855W8I"
],
"rxcui": [
"200064"
],
"spl_set_id": [
"63e54b62-a30d-4a56-9215-75e7a0b0bf02"
],
"pharm_class_epc": [
"Aromatase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Aromatase Inhibitors [MoA]"
],
"manufacturer_name": [
"Breckenridge Pharmaceutical, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51991-759_1bd709a7-993a-4e55-9bb5-d5f42678e7b9"